In part one of a two-part special presentation, NOVA reports on the trials to determine whether the new drug Interleukin-2—the first to make use of the body's own disease-fighting strategy—will live up to its promise as a pivotal cancer breakthrough. Jane Pauley of NBC News hosts and narrates.
This website contains information about a wide range of products and services. Certain details, such as prices and special offers, are provided to us by our partners and are subject to change at any time without prior notice. The information we share does not constitute legal or professional advice or forecast, and should not be treated as such.
By using our content, products & services you agree to our Terms of Use and Privacy Policy.
